Proinflammatory effects of malondialdehyde in lymphocytes

Journal of Leukocyte Biology

Volumn 92, Issue 5, 2012, Pages 1055-1067

  Raghavan, Somasundaram ^a   Subramaniyam, Ganesan ^b   Shanmugam, Narkunaraja ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

^b Department of Biochemistry   (India)

Author keywords

Cytokines; Diabetes; Lymphocytes; Malondialdehyde; Oxidative stress; Signaling pathways

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; BISINDOLYLMALEIMIDE; CYTOKINE; CYTOKINE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 25; INTERLEUKIN 6; INTERLEUKIN 8; MALONALDEHYDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C;

ARTICLE; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETIC PATIENT; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INGENUITY PATHWAY ANALYSIS; LEUKEMIA CELL LINE; LIPID PEROXIDATION; LYMPHOCYTE ACTIVATION; MOLECULE; OXIDATIVE STRESS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CYTOKINES; DIABETES MELLITUS; HUMANS; INFLAMMATION; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MALONDIALDEHYDE; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTOME; TRANSFECTION;

ANIMALIA;

EID: 84868315238     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1211617     Document Type: Article

References (48)

1. Thorpe, S. R., Baynes, J. W. (2003) Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 25, 275-281.
2. Portero-Otin, M., Bellmunt, M. J., Requena, J. R., Pamplona, R. (2003) Protein modification by advanced Maillard adducts can be modulated by dietary polyunsaturated fatty acids. Biochem. Soc. Trans. 31, 1403-1405.
3. Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., Witz-tum, J. L. (1994) ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler. Thromb. 14, 605-616.
4. Esterbauer, H., Schaur, R. J., Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128.
5. Park, H. R., Park, M., Choi, J., Park, K. Y., Chung, H. Y., Lee, J. (2010) A high-fat diet impairs neurogenesis: involvement of lipid peroxidation and brain-derived neurotrophic factor. Neurosci. Lett. 482, 235-239.
6. Suzuki, D., Miyata, T., Saotome, N., Horie, K., Inagi, R., Yasuda, Y., Uchida, K., Izuhara, Y., Yagame, M., Sakai, H. (1999) Immunohisto-chemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J. Am. Soc. Nephrol. 10, 822-832.
7. Yamada, S., Kumazawa, S., Ishii, T., Nakayama, T., Itakura, K., Shibata, N., Kobayashi, M., Sakai, K., Osawa, T., Uchida, K. (2001) Immuno-chemical detection of a lipofuscin-like fluorophore derived from malon-dialdehyde and lysine. J. Lipid Res. 42, 1187-1196.
8. Requena, J. R., Fu, M. X., Ahmed, M. U., Jenkins, A. J., Lyons, T. J., Thorpe, S. R. (1996) Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 11(SUPPL. 5), 48-53.
9. Requena, J. R., Fu, M. X., Ahmed, M. U., Jenkins, A. J., Lyons, T. J., Baynes, J. W., Thorpe, S. R. (1997) Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein. Biochem. J. 322, 317-325.
10. Huang, G. S., Wang, Z. P., Wang, S. C., Sun, T. J., Chu, R., Mao, S. J. (1999) Intracellular generation of MDA-LYS epitope in foam cells. Life Sci. 65, 285-296.
11. Furfaro, A. L., Menini, S., Patriarca, S., Pesce, C., Odetti, P., Cottalasso, D., Marinari, U. M., Pronzato, M. A., Traverso, N. (2005) HNE-depen-dent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin. Biofactors 24, 291-298.
12. Brownlee, M., Cerami, A., Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321.
13. Del Rio, D., Stewart, A. J., Pellegrini, N. (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxi-dative stress. Nutr. Metab. Cardiovasc. Dis. 15, 316-328.
14. Baynes, J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
15. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
16. Shanmugam, N., Reddy, M. A., Guha, M., Natarajan, R. (2003) High glucose-induced expression of proinflammatory cytokine and chemo-kine genes in monocytic cells. Diabetes 52, 1256-1264.
17. Schmidt, A. M., Hori, O., Brett, J., Yan, S. D., Wautier, J. L., Stern, D. (1994) Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 14, 1521-1528.
18. Schmidt, A. M., Yan, S. D., Wautier, J. L., Stern, D. (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 84, 489-497.
19. Morohoshi, M., Fujisawa, K., Uchimura, I., Numano, F. (1995) The effect of glucose and advanced glycosylation end products on IL6 production by human monocytes. Ann. N. Y. Acad. Sci. 748, 562-570.
20. Figarola, J. L., Shanmugam, N., Natarajan, R., Rahbar, S. (2007) Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes 56, 647-655.
21. Shanmugam, N., Kim, Y. S., Lanting, L., Natarajan, R. (2003) Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J. Biol. Chem. 278, 34834-34844.
22. Shanmugam, N., Ransohoff, R. M., Natarajan, R. (2006) Interferon-gamma-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100b. J. Biol. Chem. 281:31212-31221.
23. Devaraj, S., Glaser, N., Griffen, S., Wang-Polagruto, J., Miguelino, E., Jialal, I. (2006) Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55, 774-779.
24. Shanmugam, N., Figarola, J. L., Li, Y., Swiderski, P. M., Rahbar, S., Nat-arajan, R. (2008) Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes 57, 879-888.
25. Guha, M., Bai, W., Nadler, J. L., Natarajan, R. (2000) Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275, 17728-17739.
26. Ishii, H., Koya, D., King, G. L. (1998) Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J. Mol. Med. 76, 21-31.
27. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790.
28. Miyata, T., Sugiyama, S., Suzuki, D., Inagi, R., Kurokawa, K. (1999) Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy. Kidney Int. Suppl. 71, S54-S56.
29. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874.
30. Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269, 9889-9897.
31. Xue, J. H., Yuan, Z., Wu, Y., Liu, Y., Zhao, Y., Zhang, W. P., Tian, Y. L., Liu, W. M., Liu, Y., Kishimoto C. (2010) High glucose promotes intra-cellular lipid accumulation in vascular smooth muscle cells by impairing cholesterol influx and efflux balance. Cardiovasc. Res. 86, 141-150.
32. Rondeau, P., Singh, N. R., Caillens, H., Tallet, F., Bourdon, E. (2008) Oxidative stresses induced by glycoxidized human or bovine serum albumin on human monocytes. Free Radic. Biol. Med. 45, 799-812.
33. Gilmore, T. D. NF-κB transcription factors [electronic version]. Retrieved July 3, 2011, from http://www.bu.edu/nf-kb/the-gilmore-lab/ home/.
34. Entrez Gene: YY1 transcription factor. Retrieved July 3, 2011, from http://www.ncbi.nlm.nih.gov/gene/7528.
35. Sakata, N., Uesugi, N., Takebayashi, S. (2001) Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis. Cardiovasc. Res. 49, 466-475.
36. Wong, C. K, Ip, W. K, Lam, C. W. (2003) IL3, -5, and GM-CSF-induced adhesion molecule expression on eosinophils by p38 MAPK and NF-κB. Am. J. Respir. Cell Mol. Biol. 29, 114-133.
37. Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B. (2007) IL25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204, 161-170.
38. Lee, W. H., Kim, S. H., Lee, Y., Lee, B. B., Kwon, B., Song, H., Kwon, B. S., Park, J. E. (2001) Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler. Thromb. Vasc. Biol. 21, 2004-2010.
39. Zhang, M., Guo, R, Zhai, Y., Fu, X. Y, Yang, D. (2003) LIGHT stimulates IFN7-mediated intercellular adhesion molecule-1 upregulation of cancer cells. Hum. Immunol. 64, 416-426.
40. Dahl, C. P., Gullestad, L., Fevang, B., Holm, A. M., Landrø, L., Vinge, L. E., Fiane, A. E., Sandberg, W. J., Otterdal, K., Frøland, S. S. (2008) Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure. Eur. J. Heart Fail. 10, 352-359.
41. Lo, J. C, Wang, Y, Tumanov, A. V., Bamji, M., Yao, Z., Reardon, C. A, Getz, G. S., Fu, Y X. (2007) Lymphotoxin /3 receptor-dependent control of lipid homeostasis. Science 316, 285-288.
42. Emanuele, E., Falcone, C, D'Angelo, A, Minoretti, P., Buzzi, M. P., Ber-tona, M., Geroldi, D. (2006) Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease. Atherosclerosis 186, 140-145.
43. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R (2001) IL25 induces IL4, IL5, and IL13 and Th2-associated pathologies in vivo. Immunity 15, 985-995.
44. Hurst, S. D., Muchamuel, T., Gorman, D. M., Gilbert, J. M., Clifford, T., Kwan, S., Menon, S., Seymour, B., Jackson, C, Kung, T. T. (2002) New IL17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL25. J. Immunol. 169, 443-453.
45. Kang, C. M., Jang, A. S., Ahn, M. H., Shin, J. A, Kim, J. H., Choi, Y S., Rhim, T. Y, Park, C. S. (2005) Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles. Am. J. Respir Cell Mol. Biol. 33, 290-296.
46. Owyang, A. M., Zaph, C, Wilson, E. H., Guild, K. J., McClanahan, T., Miller, H. R, Cua, D. J., Goldschmidt, M., Hunter, C. A, Kastelein, R A. (2006) Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J. Exp. Med. 203, 843-849.
47. Pan, G., French, D., Mao, W., Maruoka, M., Risser, P., Lee, J., Foster, J., Aggarwal, S., Nicholes, K., Guillet, S. (2001) Forced expression of murine IL17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J. Immunol. 167, 6559-6567.
48. Kim, M. R, Manoukian, R, Yeh, R. (2002) Transgenic overexpression of human IL17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. Blood 100, 2330-2340.